IPO registrations (S-1, F-1) · Registrants

FILANA THERAPEUTICS, INC.

SEC CIK

1069530 · filings on EDGAR ↗

Name on the registration

PAIN THERAPEUTICS INC

Former names

CASSAVA SCIENCES INC (2018–2026); PAIN THERAPEUTICS INC (2000–2019)

Registration

Form S-1, first filed 2000-03-14, last 2018-12-18; 2 initial registrations, 3 amendments

Outcome

Final prospectus filed 2000-07-14; declared effective 2010-08-10; withdrawal requested 2003-08-14

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, Austin, TX 78731

EIN

91-1911336

Ticker

FLNA (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

FILANA THERAPEUTICS, INC. on the corporate pages

Offering terms

Proposed price range

$11.00–$13.00 per share (S-1/A filed 2000-07-11)

Final price

$12.00 per share, within the range (424B1 filed 2000-07-14, an initial public offering)

Shares sold

5,000,000

Gross proceeds

$60,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol PTIE

Lead underwriters

Thomas Weisel Partners (2,444,000 shares)

Syndicate

CIBC World Markets (2,021,000); Tucker Anthony Cleary Gull; Tucker Anthony Incorporated (235,000); J.P. Morgan (80,000); Donaldson, Lufkin & Jenrette (80,000); Wachovia (80,000); Raymond James (60,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: FILANA THERAPEUTICS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: CASSAVA SCIENCES, INC. EXACT (EIN (EXACT))
• Form D issuer: PAIN THERAPEUTICS INC EXACT (CIK (EXACT))
• SEC filer: CASSAVA SCIENCES INC EXACT (CIK (EXACT))

Filings 13

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.